This information was published on 2021-05-19T00:24:44 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2164296 (IR 1581955) |
| (220) |
08 Jan 2021
|
| (300) |
GB, 18 Dec 2020, UK00003569645
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical and medicinal preparations and substances; vaccines. |
| (540) | RYNTRAVIK |
| (550) | Word |
| (730) |
Glaxo Group Limited
|
Find out more about publications on the About page.